SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27

被引:1323
作者
Carrano, AC
Eytan, E
Hershko, A
Pagano, M
机构
[1] NYU, Med Ctr, Dept Pathol, New York, NY 10016 USA
[2] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Biochem Unit, IL-31096 Haifa, Israel
[3] NYU, Med Ctr, Kaplan Comprehens Canc Ctr, New York, NY 10016 USA
关键词
D O I
10.1038/12013
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Degradation of the mammalian cyclin-dependent kinase (CDK) inhibitor p27 is required for the cellular transition from quiescence to the proliferative state. The ubiquitination and subsequent degradation of p27 depend on its phosphorylation by cyclin-CDK complexes. However, the ubiquitin-protein ligase necessary for p27 ubiquitination has not been identified. Here we show that the F-box protein SKP2 specifically recognizes p27 in a phosphorylation-dependent manner that is characteristic of an F-box-protein-substrate interaction. Furthermore, both in vivo and in vitro, SKP2 is a rate-limiting component of the machinery that ubiquitinates and degrades phosphorylated p27, Thus, p27 degradation is subject to dual control by the accumulation of both SKP2 and cyclins following mitogenic stimulation.
引用
收藏
页码:193 / 199
页数:7
相关论文
共 48 条
  • [21] The Ste16 WD-repeat protein regulates cell-cycle progression under starvation through the Rum1 protein in Schizosaccharomyces pombe
    Maekawa, H
    Kitamura, K
    Shimoda, C
    [J]. CURRENT GENETICS, 1998, 33 (01) : 29 - 37
  • [22] Interaction between ubiquitin-protein ligase SCFSKP2 and E2F-1 underlies the regulation of E2F-1 degradation
    Marti, A
    Wirbelauer, C
    Scheffner, M
    Krek, W
    [J]. NATURE CELL BIOLOGY, 1999, 1 (01) : 14 - 19
  • [23] Protein marker linked with poor cancer outcome
    Mayor, S
    [J]. BRITISH MEDICAL JOURNAL, 1997, 314 (7077) : 323 - 323
  • [24] Michel JJ, 1998, CELL GROWTH DIFFER, V9, P435
  • [25] Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation
    Montagnoli, A
    Fiore, F
    Eytan, E
    Carrano, AC
    Draetta, GF
    Hershko, A
    Pagano, M
    [J]. GENES & DEVELOPMENT, 1999, 13 (09) : 1181 - 1189
  • [26] Cdk2-dependent phosphorylation of p27 facilitates its Myc-induced release from cyclin E/cdk2 complexes
    Muller, D
    Bouchard, C
    Rudolph, B
    Steiner, P
    Stuckmann, I
    Saffrich, R
    Ansorge, W
    Huttner, W
    Eilers, M
    [J]. ONCOGENE, 1997, 15 (21) : 2561 - 2576
  • [27] OCONNOR PM, 1995, CELL CYCLE MAT METHO, P63
  • [28] ROLE OF THE UBIQUITIN-PROTEASOME PATHWAY IN REGULATING ABUNDANCE OF THE CYCLIN-DEPENDENT KINASE INHIBITOR P27
    PAGANO, M
    TAM, SW
    THEODORAS, AM
    BEERROMERO, P
    DELSAL, G
    CHAU, V
    YEW, PR
    DRAETTA, GF
    ROLFE, M
    [J]. SCIENCE, 1995, 269 (5224) : 682 - 685
  • [29] ASSOCIATION OF CDK2 KINASE WITH THE TRANSCRIPTION FACTOR-E2F DURING S-PHASE
    PAGANO, M
    DRAETTA, G
    JANSENDURR, P
    [J]. SCIENCE, 1992, 255 (5048) : 1144 - 1147
  • [30] REGULATION OF THE CELL-CYCLE BY THE CDK2 PROTEIN-KINASE IN CULTURED HUMAN FIBROBLASTS
    PAGANO, M
    PEPPERKOK, R
    LUKAS, J
    BALDIN, V
    ANSORGE, W
    BARTEK, J
    DRAETTA, G
    [J]. JOURNAL OF CELL BIOLOGY, 1993, 121 (01) : 101 - 111